ORIC Oric Pharmaceuticals Inc.
Health Care, filed as ORIC PHARMACEUTICALS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 Andreas Halvorsen trimmed Oric Pharmaceuticals, and Nathan Fischel sold out.
Who owns this now
Largest portfolio weights among holders, up to 0.2% (Andreas Halvorsen, Viking Global Investors). Not free-float ownership.
Who owns ORIC
Sorted by value, long equity only, as of 2026 Q2. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| Andreas Halvorsen, Viking Global Investors | Reduce −12.0% | 5,126,762 | $56M | History | |
| Nathan Fischel, Dafna Capital Management exited 2026 Q2 Last 2026 Q1 | Exit −0.22% | 98,724 | $945K | History |
Insider trades
Open-market buys and sales by ORIC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $2.5M sold by 2 insiders under 10b5-1 plans
-
Dominic Piscitelli CFOPlanned sale$189K 14,000 shares at $13.53 17% of stakeTraded Oct 20 Filed Oct 21
-
Richard A. Heyman DirectorPlanned sale$87K 6,700 shares at $12.91Traded Oct 1 Filed Oct 2
-
Dominic Piscitelli CFOPlanned sale$181K 13,400 shares at $13.53 16% of stakeTraded Sep 28 Filed Sep 29
-
Dominic Piscitelli CFOPlanned sale$8,103 600 shares at $13.50 0.9% of stakeTraded Sep 24 Filed Sep 25
-
Dominic Piscitelli CFOPlanned sale$1.1M 77,000 shares at $13.69 52% of stakeTraded Aug 26 Filed Aug 28
-
Richard A. Heyman DirectorPlanned sale$157K 13,100 shares at $12.02Traded Jul 24 Filed Jul 28
-
Richard A. Heyman DirectorPlanned sale$3,600 300 shares at $12.00 0.1% of stakeTraded Jul 6 Filed Jul 8
-
Dominic Piscitelli CFOPlanned sale$703K 52,000 shares at $13.51 43% of stakeTraded Feb 24 Filed Feb 26
-
Richard A. Heyman DirectorPlanned sale$80K 6,700 shares at $12.00Traded Jan 16 Filed Jan 20
Also filed in the last 12 months, not counted as buying or selling: 13 option exercises and 3 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $212.6M | $262.25M | $288.47M |
| Total non-current assets * | $39.41M | $11.89M | $120.42M |
| Total assets | $252.01M | $274.14M | $408.89M |
| Total current liabilities | $20.46M | $24.85M | $20.42M |
| Total non-current liabilities * | $7.46M | $6.17M | $4.11M |
| Total equity | $224.09M | $243.12M | $384.36M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.